Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00900835 · ClinicalTrials.gov registry record · NA

Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer

A NA study, sponsored by City of Hope Medical Center.

Completed
Registry status
NA
Development phase
470
Enrollment target

NCT00900835: Completed NA study, sponsored by City of Hope Medical Center.

NCT00900835 is a NA study that has completed, run by City of Hope Medical Center. The registered enrollment target is 470 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00900835, a NA study, has completed, sponsored by City of Hope Medical Center.

COMPLETED
Registry status
NA
Development phase
470 participants
Enrollment target

Study Summary

RATIONALE: Collecting information over time about patients' and health care providers' understanding of pain and fatigue and providing education about pain and fatigue management may improve quality of life. PURPOSE: This clinical trial is studying pain and fatigue management in patients with breast cancer, prostate cancer, colon cancer, or lung cancer.

Interventions

  • OTHER questionnaire administration
  • OTHER educational intervention
  • OTHER study of socioeconomic and demographic variables
  • PROCEDURE assessment of therapy complications
  • PROCEDURE fatigue assessment and management

Trial Details

FieldValue
Enrollment Target 470 participants
Start Date 2005-06
Est. Completion 2010-08
Phase NA
City of Hope Medical Center

582 total trials

What the finished NCT00900835 record still lists

NCT00900835 is an interventional study that assigns participants to a tested intervention. The registered 470 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).

The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.

NCT00900835 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00900835 about?

NCT00900835 is a clinical study titled "Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer". RATIONALE: Collecting information over time about patients' and health care providers' understanding of pain and fatigue and providing education about pain and fatigue management may improve quality of life. PURPOSE: This clinical trial is studying pain and fatigue management in patients with breas...

What is the current status of trial NCT00900835?

This trial is currently completed. It is a NA study. The enrollment target is 470 participants. The study started on 2005-06. Estimated completion is 2010-08.

What interventions are being tested in trial NCT00900835?

The interventions under investigation include: questionnaire administration (OTHER), educational intervention (OTHER), study of socioeconomic and demographic variables (OTHER), assessment of therapy complications (PROCEDURE), fatigue assessment and management (PROCEDURE).

Who is sponsoring clinical trial NCT00900835?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00900835's enrollment target sits among peer trials

470 221st of 2000 higher than 1,779 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05256940 · 470 participants · NA

    Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk for Suicide

  • NCT05458219 · 470 participants · Phase 1

    A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

  • NCT05850689 · 470 participants · Phase 3

    Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  • NCT05935384 · 470 participants

    SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00900835, the US trial registry maintained by the National Library of Medicine. NCT00900835 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.